EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS094-29131 
Organism
Homo sapiens 
Tissue/cell
hMADS-3 
Coordinate
chr3:194246640-194249240 
Target genes
Number: 10             
NameEnsembl ID
TF binding sites/motifs
Number: 51             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr3:194247698-194247716GGAAGGAAGGAAGGAAGA+10.05
EWSR1-FLI1MA0149.1chr3:194247694-194247712GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr3:194248749-194248767CCCGCCTTCCTTCCCTCT-6.03
EWSR1-FLI1MA0149.1chr3:194248620-194248638TCTTCCTTCTTTCTTTTC-6.05
EWSR1-FLI1MA0149.1chr3:194248608-194248626CTTCTCTTCCTTTCTTCC-6.09
EWSR1-FLI1MA0149.1chr3:194248723-194248741CCTTGCTTCCATTCTTTC-6.09
EWSR1-FLI1MA0149.1chr3:194248553-194248571ATGCCCTTCCTTCCTTCC-6.14
EWSR1-FLI1MA0149.1chr3:194247674-194247692GAAAGAAAGGAAAGAAAG+6.33
EWSR1-FLI1MA0149.1chr3:194247670-194247688GAAAGAAAGAAAGGAAAG+6.34
EWSR1-FLI1MA0149.1chr3:194248616-194248634CCTTTCTTCCTTCTTTCT-6.56
EWSR1-FLI1MA0149.1chr3:194247678-194247696GAAAGGAAAGAAAGAAGG+6.62
EWSR1-FLI1MA0149.1chr3:194248612-194248630TCTTCCTTTCTTCCTTCT-6.79
EWSR1-FLI1MA0149.1chr3:194247706-194247724GGAAGGAAGAAAGAAAGA+6.81
EWSR1-FLI1MA0149.1chr3:194248699-194248717CTTTTCTTCCTTCCTTCT-6.95
EWSR1-FLI1MA0149.1chr3:194248719-194248737CCTTCCTTGCTTCCATTC-6.98
EWSR1-FLI1MA0149.1chr3:194248565-194248583CCTTCCTCCTTCCCTTCC-7.05
EWSR1-FLI1MA0149.1chr3:194248561-194248579CCTTCCTTCCTCCTTCCC-7.08
EWSR1-FLI1MA0149.1chr3:194248711-194248729CCTTCTTTCCTTCCTTGC-7.71
EWSR1-FLI1MA0149.1chr3:194247686-194247704AGAAAGAAGGAAGGAAGG+7.85
EWSR1-FLI1MA0149.1chr3:194248557-194248575CCTTCCTTCCTTCCTCCT-7.85
EWSR1-FLI1MA0149.1chr3:194247682-194247700GGAAAGAAAGAAGGAAGG+7.87
EWSR1-FLI1MA0149.1chr3:194247702-194247720GGAAGGAAGGAAGAAAGA+8.26
EWSR1-FLI1MA0149.1chr3:194248703-194248721TCTTCCTTCCTTCTTTCC-8.52
EWSR1-FLI1MA0149.1chr3:194248715-194248733CTTTCCTTCCTTGCTTCC-8.52
EWSR1-FLI1MA0149.1chr3:194247690-194247708AGAAGGAAGGAAGGAAGG+9.09
EWSR1-FLI1MA0149.1chr3:194248707-194248725CCTTCCTTCTTTCCTTCC-9.17
Foxd3MA0041.1chr3:194249166-194249178GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr3:194249170-194249182GTTTGTTTGTTT+6.32
IRF1MA0050.2chr3:194248652-194248673TCTTTCTTTCTTTTTCTTTCT+6.14
IRF1MA0050.2chr3:194247659-194247680AAAAAAAAAAAGAAAGAAAGA-6.25
IRF1MA0050.2chr3:194247719-194247740AAAGAAAAAAAGAAAGAAAGA-6.34
IRF1MA0050.2chr3:194248638-194248659TCTTTCTTTCTCTTTCTTTCT+6.76
IRF1MA0050.2chr3:194247729-194247750AGAAAGAAAGAGAAAGAAAGA-6.76
IRF1MA0050.2chr3:194247743-194247764AGAAAGAAAGAGAAAGAAAGA-6.76
ZNF263MA0528.1chr3:194248703-194248724TCTTCCTTCCTTCTTTCCTTC-6.02
ZNF263MA0528.1chr3:194248597-194248618CCTCCCCTCCCCTTCTCTTCC-6.13
ZNF263MA0528.1chr3:194248600-194248621CCCCTCCCCTTCTCTTCCTTT-6.1
ZNF263MA0528.1chr3:194248569-194248590CCTCCTTCCCTTCCCTCCCTT-6.21
ZNF263MA0528.1chr3:194248741-194248762CCTCTCCCCCCGCCTTCCTTC-6.21
ZNF263MA0528.1chr3:194248584-194248605TCCCTTCCCCTCCCCTCCCCT-6.25
ZNF263MA0528.1chr3:194248594-194248615TCCCCTCCCCTCCCCTTCTCT-6.33
ZNF263MA0528.1chr3:194248573-194248594CTTCCCTTCCCTCCCTTCCCC-6.34
ZNF263MA0528.1chr3:194247699-194247720GAAGGAAGGAAGGAAGAAAGA+6.36
ZNF263MA0528.1chr3:194248579-194248600TTCCCTCCCTTCCCCTCCCCT-6.44
ZNF263MA0528.1chr3:194248737-194248758TTTCCCTCTCCCCCCGCCTTC-6.51
ZNF263MA0528.1chr3:194248565-194248586CCTTCCTCCTTCCCTTCCCTC-6.79
ZNF263MA0528.1chr3:194248589-194248610TCCCCTCCCCTCCCCTCCCCT-6.91
ZNF263MA0528.1chr3:194247691-194247712GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr3:194247703-194247724GAAGGAAGGAAGAAAGAAAGA+6
ZNF263MA0528.1chr3:194247695-194247716GAAGGAAGGAAGGAAGGAAGA+7.03
ZNF263MA0528.1chr3:194248556-194248577CCCTTCCTTCCTTCCTCCTTC-7.79
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_45578chr3:194246668-194248716Osteoblasts
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr3194247870194248550
Number: 1             
IDChromosomeStartEnd
GH03I194526chr3194246819194249105
Enhancer Sequence
CTGCCTCAGC CTCCCGAGTA GCTGGGATTA CAGGCATGCA CCACCACGCC TGGCTAACTT 60
TTGTTTTTTT AGTAGAGATG GAGTTTCTCC ATGTTGGTCA GGCCAGTCTG AAACTCCTGA 120
CCTCAGGTGA TCCACCTGCC TCGGCCTCCC AAAGTGCTGG GATTATAGGC GTGAACCACT 180
GTGCCTGGCC TAGTGTACCC ATTCTTTAAG GCCCCACTCC TGTCCCTTCT CCCTACCACT 240
GTCCCTGCCT CTTACCCAAC CAGTTGTCTT TCTCTCTTGT AAACTCCAAC ATTTCACATT 300
TATCTCTTGT TATATGTGGC TAGTAACCAT TGATCACCTT CCTTATGTTT GCTCATGTTT 360
TACCTTCCCA GCTAGTCTGT ATGCTTCTCG AAGGCTAGGC TCATATTGCA CATCATTGTA 420
TCTTCTTTGC CCTCTGGAAG GCTAGGATCA TATTGCGCAT CATTGTATCT TCTTTGCCCT 480
CTGGAAGGCT AGGATCATAT TGCGCATCAT TGTATCTTCT TTGCCCCCGG AGCATGGCCT 540
GCCTAGAGGG GATATTTGGT CATTTCTTTT TCATTGATTG GTTTTATAAC CACCATAATG 600
TTTGAACTCC TTAATGTGGC CTACATGGAT TGGTCTTTGC CACCCTATTT GGCCTCATTT 660
GTGTCTCCTC CCCCTTTACA TTTTATACCT AGCCATCCTC AATACCAGCC AGTTCCTTAG 720
AAATTCCATG GGCCAAGCAC AGTGGCTCAT CACACCTGTA ATCCCAGCAC TTTGGGAGGC 780
CGAAGCGGGC GGATCACCTG AGGTCAGTAG TTCCAGACCA GCCTGACCAA CACGGTGAAA 840
CCCCATCTCT ACTAAAATAC AAAAATTAGC CAGTTGTGGT GGTGCACGCC TGTAATCCCA 900
GCTTCTCGGG AGGCTGAGGC AGGAGAATCG CTTGAACCCA GGAGGTGGGG GTTGCAGTGA 960
GCCCAGATCG CCCTACTGCA CTCTAGCTTG GGTGACAGGG CAGTGACCCT GTCTCAAAAA 1020
AAAAAAAAAA GAAAGAAAGA AAGGAAAGAA AGAAGGAAGG AAGGAAGGAA GGAAGAAAGA 1080
AAGAAAAAAA GAAAGAAAGA GAAAGAAAGA AAGAGAAAGA AAGAAAAGAA GAAAGAAAGA 1140
AAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA 1200
AAAATTGCAG CCATGACACC TCACACAGCT TCCTCTGCCG GAACACTCAT CTCCTCTTCT 1260
GTCTGGTTGA CTCTTCTCAA CATTTGCATC TCAATCTGGG AATTACTTCC TAACGAGAAG 1320
TCTTCCCCTG GACTTCATCA GAAAGTACAA ATTAGTAAGA TTGCGCCAGC AAAATGCGTA 1380
GTGTGTGAGA AAGCACTTAG CAAGAGGAAA TGAGAAACAT TCACGTCCAC TTACTCATGA 1440
GCTTGCTCCA GCTTCTTCTT CTCCTGTCCC CTAGTTCCCT CTGGATGTCA GCCATCTGAA 1500
ATTACTCACA GGACATCTGA ATGCACTTTG TTTTATCATA CAAAGTGTGC CTTTGTACAC 1560
ACTTTTCTTC CGTTTTTTTT CTTCCTTTTT TTTTTTTTTT TGGAGGCCAA GTGCACTGAC 1620
GCCATTTCGG CTCATTGCAA CCCCTGCCTC CTGGGTTCAA GCTATTCTCC TGCCTCAGCC 1680
TCCCAAGTAG CTGGGACTAC AGGTGTGTAC CACCATGCCT GACTAATTTT TGTATTTTTA 1740
GTAGAGATGG GGTTTCACCA TGTTGGCCAG GCTGGTCTCG AACCCTGACC TCAAGTGATC 1800
CACCCACCTC GGCCTCTCAA AGTTCTGGGA TTACAGGTGT GAGCCATTAT GCCCAGCCTG 1860
TACACACTAA ACATTTTTCA TTTTTTCATT CTTCCTAGGA TTCCATTTAA TCCATGCCCT 1920
TCCTTCCTTC CTCCTTCCCT TCCCTCCCTT CCCCTCCCCT CCCCTCCCCT TCTCTTCCTT 1980
TCTTCCTTCT TTCTTTTCTC TTTCTTTCTC TTTCTTTCTT TCTTTTTCTT TCTTTCTTCT 2040
GTTCTTTCCT TCTTTTGTTC TTTTCTTCCT TCCTTCTTTC CTTCCTTGCT TCCATTCTTT 2100
CCCTCTCCCC CCGCCTTCCT TCCCTCTCTC TCCACACCCC TACCCCCGCC CTTCTCTTTC 2160
TTTTGAGAGT CTTACTCTAT TGCCCAGGAT GGAGTGCAAT GGTGCCATCA CAGCTCACTG 2220
CAACCTCTGC CTCCCGGGTT CAAGTGATCT TCGTGCCTCA GCCACCTGAG TAGCTGTGGG 2280
ATTACAAGTA TCTGCAATCA GGTCTGGCTA ATTTTTGTAT TTTTAGTAGA TATGGGGTTT 2340
CACCGTGTTG GCCAGGCTGG TCTTCAACTC CTGGCCTCAA GTGATCCACC CACCTCGGTC 2400
TCCCAAAGTG CTGGGATTAA AGGCATGAGC CACCGCGTGG CCTAATCCAT GCCCTTTCTT 2460
CACCTAATTA ACTCCTACTC ATTTTTCAAT GCCCAGCCAA GGGGTTTGTA TAATGGTGCA 2520
ATTTTTGTTT GTTTGTTTGT TTTATGAGAC GGTCTTGCTC TGTCACCCAG GCTGGAGTGC 2580
AGTGGTACGA TTTTGGCTCA 2600